# OnCo record day-one-biopharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/day-one-biopharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "day-one-biopharmaceuticals" ;
  schema:name "Day One Biopharmaceuticals"@en ;
  schema:description "Paediatric-first oncology company whose tovorafenib became the first targeted therapy approved for childhood low-grade glioma driven by BRAF fusions, following dabrafenib with trametinib (2023) for BRAF V600E tumours."@en ;
  schema:url <https://onco.cc/companies/day-one-biopharmaceuticals/>, <https://www.dayonebio.com> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.dayonebio.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/tovorafenib/> ;
  onco:trials <https://onco.cc/trials/nct05377996/>, <https://onco.cc/trials/nct05566795/> .